ENTRY       D00961                      Drug
NAME        Bicalutamide (JP18/USP/INN);
            Casodex (TN)
PRODUCT     BICALUTAMIDE (ANI Pharmaceuticals)
            CASODEX (ANI Pharmaceuticals)
  GENERIC   BICALUTAMIDE (Accord Healthcare)
            BICALUTAMIDE (Bryant Ranch Prepack)
            BICALUTAMIDE (Golden State Medical Supply)
            BICALUTAMIDE (Major Pharmaceuticals)
            BICALUTAMIDE (Northstar RxLLC)
            BICALUTAMIDE (Proficient Rx LP)
            BICALUTAMIDE (Sun Pharmaceutical Industries)
FORMULA     C18H14F4N2O4S
EXACT_MASS  430.061
MOL_WEIGHT  430.3734
CLASS       Antineoplastic
             DG01591  Androgen receptor antagonist
              DG01624  Flutamide-type antiandrogen
            Metabolizing enzyme inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
REMARK      Same as: C08160
            Therapeutic category: 4291
            ATC code: L02BB03
            Product: D00961<JP/US>
EFFICACY    Antineoplastic, Androgen receptor antagonist
  DISEASE   Prostate cancer [DS:H00024]
TARGET      NR3C4 (AR) [HSA:367] [KO:K08557]
  PATHWAY   hsa05200(367)  Pathways in cancer
            hsa05215(367)  Prostate cancer
INTERACTION CYP inhibition: CYP3A4 [HSA:1576]
STR_MAP     map07043  Antineoplastics - hormones
            map07226  Progesterone, androgen and estrogen receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L02 ENDOCRINE THERAPY
               L02B HORMONE ANTAGONISTS AND RELATED AGENTS
                L02BB Anti-androgens
                 L02BB03 Bicalutamide
                  D00961  Bicalutamide (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antiandrogens
               Bicalutamide
                D00961  Bicalutamide (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D00961  Bicalutamide (JP18/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01591  Androgen receptor antagonist
               DG01624  Flutamide-type antiandrogen
                D00961  Bicalutamide
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                D00961  Bicalutamide
            Drug classes [BR:br08332]
             Antineoplastic
              DG01591  Androgen receptor antagonist
               D00961  Bicalutamide
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                NR3C4 (AR)
                 D00961  Bicalutamide (JP18/USP/INN) &lt;JP/US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00961
DBLINKS     CAS: 90357-06-5
            PubChem: 7848024
            ChEBI: 3090
            PDB-CCD: 0U9
            LigandBox: D00961
            NIKKAJI: J391.515H
ATOM        29
            1   C8y C    41.7900  -19.3200
            2   C8y C    41.7900  -20.7200
            3   C8x C    40.5300  -18.6200
            4   C1d C    42.9800  -18.6200
            5   C8x C    40.5300  -21.4200
            6   C3b C    42.9800  -21.4200
            7   C8y C    39.3400  -19.3200
            8   X   F    44.1700  -17.9200
            9   X   F    42.2800  -17.4300
            10  X   F    43.6800  -19.8100
            11  C8x C    39.3400  -20.7200
            12  N3a N    44.1700  -22.1200
            13  N1b N    38.1500  -18.6200
            14  C5a C    36.9600  -19.3200
            15  C1d C    35.7000  -18.6200
            16  O5a O    36.9600  -20.7200
            17  C1b C    34.5100  -19.3200
            18  C1a C    35.7000  -17.2200
            19  S4a S    33.3200  -18.6200
            20  C8y C    32.0600  -19.3200
            21  O3c O    32.3400  -17.6400
            22  O3c O    34.2300  -17.5700
            23  O1a O    35.7000  -20.0200
            24  C8x C    32.0600  -20.7200
            25  C8x C    30.8700  -21.4200
            26  C8y C    29.6800  -20.7200
            27  C8x C    29.6800  -19.3200
            28  C8x C    30.8700  -18.6200
            29  X   F    28.4200  -21.4200
BOND        30
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     4   9 1
            9     4  10 1
            10    5  11 1
            11    6  12 3
            12    7  13 1
            13   13  14 1
            14   14  15 1
            15   14  16 2
            16   15  17 1
            17   15  18 1 #Down
            18   17  19 1
            19   19  20 1
            20   19  21 2
            21   19  22 2
            22    7  11 2
            23   15  23 1 #Up
            24   20  24 2
            25   24  25 1
            26   25  26 2
            27   26  27 1
            28   27  28 2
            29   20  28 1
            30   26  29 1
///
